$149.37 0.3%
JNJ Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Johnson & Johnson
Price $149.37
Target Price Sign up
Volume 270,740
Market Cap $361B
Year Range $143.28 - $161.42
Dividend Yield 3.31%
PE Ratio 22.27
Revenue per Employee $674,496
Earnings Date July 17 '24
Industry Drug Manufacturers

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2421.2B13.2B14.9B3.26B4.97B2.710
Q4 '2321.4B14.1B14.6B4.05B5.99B2.290
Q3 '2321.2B13.3B14.7B26B28.2B2.660
Q2 '2325.2B16.2B15.1B5.14B8.31B2.800
Q1 '2320.9B300M14.2B-68M678M2.680

Insider Transactions View All

Broadhurst Vanessa filed to sell 15,043 shares at $162.2.
March 13 '24
Taubert Jennifer L filed to sell 141,416 shares at $156.3.
February 12 '24
Hait William filed to sell 87,747 shares at $172.
July 27 '23
Fasolo Peter filed to sell 102,696 shares at $170.3.
July 27 '23
Swanson James D. filed to sell 9,215 shares at $154.7.
March 8 '23

What is the Market Cap of Johnson & Johnson?

The Market Cap of Johnson & Johnson is $361B.

What is Johnson & Johnson's PE Ratio?

As of today, Johnson & Johnson's PE (Price to Earnings) ratio is 22.27.

How Many People Work at Johnson & Johnson?

As of our latest update, Johnson & Johnson employed approximately 131,900 people worldwide. However, it's important to note that Johnson & Johnson's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Johnson & Johnson's revenue per employee?

$674,496. To calculate Johnson & Johnson's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

When does Johnson & Johnson report earnings?

Johnson & Johnson will report its next earnings on July 17 '24.

What is the current stock price of Johnson & Johnson?

Currently, the price of one share of Johnson & Johnson stock is $149.37.

How can I analyze the JNJ stock price chart for investment decisions?

The JNJ stock price chart above provides a comprehensive visual representation of Johnson & Johnson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Johnson & Johnson shares. Our platform offers an up-to-date JNJ stock price chart, along with technical data analysis and alternative data insights.

Does JNJ offer dividends to its shareholders?

Yes, Johnson & Johnson (JNJ) offers dividends to its shareholders, with a dividend yield of 3.31%. This dividend yield represents Johnson & Johnson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Johnson & Johnson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Johnson & Johnson?

Some of the similar stocks of Johnson & Johnson are Eli Lilly and Company, Pfizer, Astrazeneca, AbbVie, and TherapeuticsMD.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.